Medical abortion reversal: science and politics meet

被引:7
|
作者
Bhatti, Khadijah Z. [1 ]
Nguyen, Antoinette T. [1 ]
Stuart, Gretchen S. [1 ]
机构
[1] Univ N Carolina, Dept Obstet & Gynecol, Sch Med, Chapel Hill, NC USA
关键词
medical abortion; mifepristone; reversal; MIFEPRISTONE; ACCEPTABILITY; PREGNANCY; SAFETY;
D O I
10.1016/j.ajog.2017.11.555
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Medical abortion is a safe, effective, and acceptable option for patients seeking an early nonsurgical abortion. In 2014, medical abortion accounted for nearly one third (31%) of all abortions performed in the United States. State-level attempts to restrict reproductive and sexual health have recently included bills that require physicians to inform women that a medical abortion is reversible. In this commentary, we will review the history, current evidence-based regimen, and regulation of medical abortion. We will then examine current proposed and existing abortion reversal legislation. The objective of this commentary is to ensure physicians are armed with rigorous evidence to inform patients, communities, and policy makers about the safety of medical abortion. Furthermore, given the current paucity of evidence for medical abortion reversal, physicians and policy makers can dispel bad science and misinformation and advocate against medical abortion reversal legislation.
引用
收藏
页码:315 / +
页数:6
相关论文
共 50 条
  • [41] Misoprostol priming prior to second trimester medical abortion
    Moreno-Ruiz, Nilda L.
    Vesona, Jenny L.
    Betstadt, Sarah J.
    Feng, Kui-Tzu
    Borgatta, Lynn
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2009, 106 (01) : 67 - 68
  • [42] Clinic-level introduction of medical abortion in Vietnam
    Raghavan, Sheila
    Nguyen Thi Nhu Ngoc
    Shochet, Tara
    Winikoff, Beverly
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2012, 119 (01) : 39 - 43
  • [43] Structural barriers or patient preference? A mixed methods appraisal of medical abortion use in England and Wales
    Footman, Katy
    HEALTH POLICY, 2023, 132
  • [44] Telemedicine medical abortion service in Georgia: an evaluation of a strategy with reduced number of in-Clinic visits
    Tsereteli, Nino
    Mamatsashvili, Lia
    Tsertsvadze, George
    Tsereteli, Tamar
    Platais, Ingrida
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2023, 28 (02) : 141 - 146
  • [45] Medical abortion in the first trimester
    Baird, DT
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2002, 16 (02) : 221 - 236
  • [46] Medical abortion in the second trimester
    Tang, OS
    Ho, PC
    BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY, 2002, 16 (02): : 237 - 246
  • [47] Impact of approval of home use of misoprostol in England on access to medical abortion: An interrupted time series analysis
    Lewandowska, Maria
    Carter, Daniel J.
    Gasparrini, Antonio
    Lohr, Patricia A.
    Wellings, Kaye
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 164 (01) : 286 - 297
  • [48] Assessment of pain during medical abortion with home use of misoprostol
    Cavet, Sandra
    Fiala, Christian
    Scemama, Agathe
    Partouche, Henri
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2017, 22 (03) : 207 - 211
  • [49] Efficacy of early induced medical abortion with mifepristone when beginning progestin-only contraception on the same day
    Douthwaite, Megan
    Candelas, Jose A.
    Reichwein, Barbara
    Eckhardt, Carla
    Ngo, Thoai D.
    Dominguez, Adriana
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2016, 133 (03) : 329 - 333
  • [50] Effects of medical abortion assisted by traditional Chinese medicine: A network meta-analysis of randomized controlled trials
    Li, Fuxing
    Han, Mei
    Zhang, Jiayu
    Ji, Jingru
    Wu, Yanfei
    Wei, Junni
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 166 (01) : 152 - 162